1. Han HC, Hawkins NM, Pearman CM, et al. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors. Europace. 2021;23(23 Suppl 4): iv3-iv10. https://doi.org/10.1093/europace/euab042.
2. Johansen JB, Jorgensen D, Moller M, et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011;32: 991-998. https://doi.org/10.1093/eurheartj/ehq497.
3. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22(4): v515-549. https://doi.org/10.1093/europace/euz246.
4. Сапельников ОВ. Осложнения экстракции электродов. В кн. Экстракция электродов сердечных имплантируемых электронных устройств: показания, методики, оснащение, ведение пациентов (Ред. Ревишвили АШ.). 2021: 103-109. ISBN 978-5-88429-268-0.
5. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12): e503-e551. https://doi.org/10.1016/j.hrthm.2017.09.001.
6. Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018;00: 1-11. https://doi.org/10.1093/europace/euy050.
7. Azarrafiy R, Tsang DC, Wilkoff BL, et al. Endovascular Occlusion Balloon for treatment of superior vena cava tears during transvenous lead extraction. A multiyear analysis and an update to best practice protocol. Circ Arrhythm Electrophysiol. 2019;12. https://doi.org/10.1161/CIRCEP.119.007266.
8. Bhullar A, Alcantara S, Yu PJ, et al. It works there too! Use of the endovascular occlusion balloon to rescue left subclavian vein injury during lead extraction. HeartRhythm Case Rep. 2021;7(6): 395-397. https://doi.org/10.1016/j.hrcr.2021.03.012.
9. Sidhu BS, Ayis S, Gould J, et al. ELECTRa Investigators Group. Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): An ESC EHRA EORP European lead extraction ConTRolled, E.L.ECTRa registry analysis. Europace. 2021: euab037. https://doi.org/10.1093/europace/ euab037.
10. Jacheć W, Polewczyk A, Polewczyk M, et al. Transvenous Lead Extraction SAFeTY Score for Risk Stratification and Proper Patient Selection for Removal Procedures Using Mechanical Tools. J Clin Med. 2020;9: 361. https://doi.org/10.3390/jcm9020361.
11. Абдрахманов АС, Пя ЮВ, Алимбаев СА, и др. Имплантация безэлектродного электрокардиостимулятора после удаления инфицированных электродов. Вестник аритмологии. 2018;(91): 57-59.
12. El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry. J Cardiovasc Electrophysiol 2019;30(4): 569-574. http://doi.org/10.1111/jce.13851.
13. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Eur Heart J. 2021;42(35):3427-3520. http://doi.org/10.1093/eurheartj/ehab364.
